PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Emiel F M Wouters Selected Research
Chronic Obstructive Pulmonary Disease (COPD)
06/2008
Metabolic and functional effects of glutamate intake in patients with chronic obstructive pulmonary disease (COPD).
01/2008
Effect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot study.
01/2008
Bronchodilating effect of combined therapy with ipratropium bromide and ondansetron in patients with COPD.
03/2007
Increased granzyme A expression in type II pneumocytes of patients with severe chronic obstructive pulmonary disease.
02/2007
Supplementation of soy protein with branched-chain amino acids alters protein metabolism in healthy elderly and even more in patients with chronic obstructive pulmonary disease.
05/2006
Effect of glutamate ingestion on whole-body glutamate turnover in healthy elderly and patients with chronic obstructive pulmonary disease.
05/2006
Exercise training restores uncoupling protein-3 content in limb muscles of patients with chronic obstructive pulmonary disease.
01/2006
Metabolic effects of glutamine and glutamate ingestion in healthy subjects and in persons with chronic obstructive pulmonary disease.
09/2005
Decreased whole-body and splanchnic glutamate metabolism in healthy elderly men and patients with chronic obstructive pulmonary disease in the postabsorptive state and in response to feeding.
12/2004
Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD.
11/2003
A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial.
07/2003
Systemic poly(ADP-ribose) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients.
04/2003
Response of whole-body protein and urea turnover to exercise differs between patients with chronic obstructive pulmonary disease with and without emphysema.
01/2002
Tumor necrosis factor-alpha +489G/A gene polymorphism is associated with chronic obstructive pulmonary disease.
Articles by Research Topic
Disease
14
Chronic Obstructive Pulmonary Disease (COPD)
06/2008 - 01/2002
3
Inflammation
01/2008 - 07/2003
1
Rheumatoid Arthritis
11/2006
1
Weight Loss (Weight Reduction)
10/2004
1
Emphysema
04/2003
Drug/Important Bio-Agent (IBA)
4
Glutamic Acid (Glutamate)
FDA Link
06/2008 - 09/2005
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
11/2006 - 01/2002
2
Glutamine (L-Glutamine)
FDA Link
01/2006 - 10/2004
1
Ondansetron (Zofran)
FDA Link
Generic
01/2008
1
infliximab (Remicade)
FDA Link
01/2008
1
Ipratropium (Ipratropium Bromide)
FDA Link
Generic
01/2008
1
Granzymes (Granzyme)
IBA
03/2007
1
Branched-Chain Amino Acids
IBA
02/2007
1
Soybean Proteins (Soy Protein)
IBA
02/2007
1
mitochondrial uncoupling protein 3
IBA
05/2006
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
01/2005
1
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
12/2004
1
Matrix Metalloproteinase 8 (Neutrophil Collagenase)
IBA
12/2004
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
10/2004
1
Steroids
IBA
11/2003
1
Poly Adenosine Diphosphate Ribose
IBA
07/2003
1
Urea (Carbamide)
FDA Link
Generic
04/2003